APA (7th ed.) Citation

E, T., S, D. M., C, M., GM, B., A, C., EL, F., . . . GL, C. (2026). Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective. ClinicoEconomics and outcomes research : CEOR, 18, 585328. https://doi.org/10.2147/CEOR.S585328

Chicago Style (17th ed.) Citation

E, Torre, et al. "Semaglutide 2.4 Mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective." ClinicoEconomics and Outcomes Research : CEOR 18 (2026): 585328. https://doi.org/10.2147/CEOR.S585328.

MLA (9th ed.) Citation

E, Torre, et al. "Semaglutide 2.4 Mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective." ClinicoEconomics and Outcomes Research : CEOR, vol. 18, 2026, p. 585328, https://doi.org/10.2147/CEOR.S585328.